LEXINGTON, Mass.--(BUSINESS WIRE)--Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) today announced that Santosh J. Vetticaden, M.D., Ph.D., has joined the company as Senior Vice President, Clinical Development and Chief Medical Officer. Dr. Vetticaden will be a member of Cubist’s executive team and report to Mike Bonney, Cubist’s President and CEO. Dr. Vetticaden will lead the development and implementation of clinical strategy for Cubist’s clinical programs, while managing and developing Clinical Research, Medical Affairs, Clinical Operations, Statistics and Data Management, and Pharmacovigilance.
